Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy.

Jiang XC, Goldberg IJ, Park TS.

Adv Exp Med Biol. 2011;721:19-39. doi: 10.1007/978-1-4614-0650-1_2. Review.

PMID:
21910080
[PubMed - indexed for MEDLINE]
2.

Sphingolipid synthetic pathways are major regulators of lipid homeostasis.

Worgall TS.

Adv Exp Med Biol. 2011;721:139-48. doi: 10.1007/978-1-4614-0650-1_9. Review.

PMID:
21910087
[PubMed - indexed for MEDLINE]
3.

Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.

Hojjati MR, Li Z, Zhou H, Tang S, Huan C, Ooi E, Lu S, Jiang XC.

J Biol Chem. 2005 Mar 18;280(11):10284-9. Epub 2004 Dec 6.

PMID:
15590644
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulation of lipid metabolism by sphingolipids.

Worgall TS.

Subcell Biochem. 2008;49:371-85. doi: 10.1007/978-1-4020-8830-8_14. Review.

PMID:
18751919
[PubMed - indexed for MEDLINE]
5.

Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?

Tabas I.

Circulation. 2004 Nov 30;110(22):3400-1. No abstract available.

PMID:
15569847
[PubMed - indexed for MEDLINE]
Free Article
6.

Lipid disorders and their relevance to outcomes in chronic kidney disease.

Vaziri ND, Norris K.

Blood Purif. 2011;31(1-3):189-96. doi: 10.1159/000321845. Epub 2011 Jan 10. Review.

PMID:
21228589
[PubMed - indexed for MEDLINE]
7.

Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.

Park TS, Rosebury W, Kindt EK, Kowala MC, Panek RL.

Pharmacol Res. 2008 Jul;58(1):45-51. doi: 10.1016/j.phrs.2008.06.005. Epub 2008 Jun 20.

PMID:
18611440
[PubMed - indexed for MEDLINE]
8.

Sphingolipids in atherosclerosis and vascular biology.

Chatterjee S.

Arterioscler Thromb Vasc Biol. 1998 Oct;18(10):1523-33. Review.

PMID:
9763522
[PubMed - indexed for MEDLINE]
Free Article
9.

Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.

Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, Pattison J, Juliano J, Miller ER, Almazan F, Crosier P, Witztum JL, Klemke RL, Miller YI.

Circ Res. 2009 Apr 24;104(8):952-60. doi: 10.1161/CIRCRESAHA.108.189803. Epub 2009 Mar 5.

PMID:
19265037
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Blood sphingolipids in homeostasis and pathobiology.

Hammad SM.

Adv Exp Med Biol. 2011;721:57-66. doi: 10.1007/978-1-4614-0650-1_4. Review.

PMID:
21910082
[PubMed - indexed for MEDLINE]
11.

Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis.

Lemaire-Ewing S, Lagrost L, NĂ©el D.

Atherosclerosis. 2012 Apr;221(2):303-10. doi: 10.1016/j.atherosclerosis.2011.10.016. Epub 2011 Oct 20. Review.

PMID:
22071358
[PubMed - indexed for MEDLINE]
12.

Sphingolipids and hepatic steatosis.

Bikman BT, Summers SA.

Adv Exp Med Biol. 2011;721:87-97. doi: 10.1007/978-1-4614-0650-1_6. Review.

PMID:
21910084
[PubMed - indexed for MEDLINE]
13.

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis.

Schwartz EA, Reaven PD.

Biochim Biophys Acta. 2012 May;1821(5):858-66. doi: 10.1016/j.bbalip.2011.09.021. Epub 2011 Oct 7. Review.

PMID:
22001233
[PubMed - indexed for MEDLINE]
Free Article
14.

Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids.

Rudel LL, Parks JS, Hedrick CC, Thomas M, Williford K.

Prog Lipid Res. 1998 Dec;37(6):353-70. Review. No abstract available.

PMID:
10209653
[PubMed - indexed for MEDLINE]
15.

Sphingolipids: major regulators of lipid metabolism.

Worgall TS.

Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):149-55. Review.

PMID:
17285002
[PubMed - indexed for MEDLINE]
16.

Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Holland WL, Summers SA.

Endocr Rev. 2008 Jun;29(4):381-402. doi: 10.1210/er.2007-0025. Epub 2008 May 1. Review.

PMID:
18451260
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease.

Rohrer L, Hersberger M, von Eckardstein A.

Curr Opin Lipidol. 2004 Jun;15(3):269-78. Review.

PMID:
15166782
[PubMed - indexed for MEDLINE]
18.

The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.

Staprans I, Pan XM, Rapp JH, Feingold KR.

Mol Nutr Food Res. 2005 Nov;49(11):1075-82. Review.

PMID:
16270280
[PubMed - indexed for MEDLINE]
19.

Vascular endothelium in atherosclerosis.

Sima AV, Stancu CS, Simionescu M.

Cell Tissue Res. 2009 Jan;335(1):191-203. doi: 10.1007/s00441-008-0678-5. Epub 2008 Sep 17. Review.

PMID:
18797930
[PubMed - indexed for MEDLINE]
20.

Lipids and the endothelium: bidirectional interactions.

Goldberg IJ, Bornfeldt KE.

Curr Atheroscler Rep. 2013 Nov;15(11):365. doi: 10.1007/s11883-013-0365-1. Review.

PMID:
24037142
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk